Target Healthcare REIT (LON:THRL - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 95.94 ($1.29) and traded as high as GBX 99 ($1.33). Target Healthcare REIT shares last traded at GBX 97.90 ($1.32), with a volume of 1,305,086 shares traded.
Target Healthcare REIT Price Performance
The business's 50-day simple moving average is GBX 96.23 and its two-hundred day simple moving average is GBX 88.92. The stock has a market cap of £615.78 million, a P/E ratio of 8.43, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44. The company has a quick ratio of 1.52, a current ratio of 7.20 and a debt-to-equity ratio of 34.92.
Target Healthcare REIT (LON:THRL - Get Free Report) last issued its earnings results on Friday, March 14th. The company reported GBX 3.06 ($0.04) EPS for the quarter. Target Healthcare REIT had a net margin of 104.99% and a return on equity of 10.78%. Sell-side analysts expect that Target Healthcare REIT will post 6.2219101 EPS for the current year.
Target Healthcare REIT Company Profile
(
Get Free Report)
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Featured Articles
Before you consider Target Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Target Healthcare REIT wasn't on the list.
While Target Healthcare REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
